Form 4: DaVita Inc. Director Acquires Shares in Recent Transaction

Director Pamela M. Arway acquired 312 shares of DaVita Inc. common stock on November 15, 2024.

Summary

• Pamela M. Arway, a director at DaVita Inc., acquired 312 shares of common stock on November 15, 2024.
• The shares were acquired at a price of $0, indicating they were likely awarded as part of a compensation package.
• Following the transaction, Ms. Arway directly owns 24,886 shares of DaVita Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the acquisition of shares by a director can be seen as a sign of confidence, but it's a routine transaction.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It does not indicate any specific trend in the healthcare industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical director share acquisitions.
• Similar filings are regularly made by directors and officers of companies like Fresenius Medical Care and Baxter International, which are competitors of DaVita in the dialysis and healthcare space.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.

Key Dates

Keywords

DaVita Inc., director, share acquisition, Pamela M. Arway, common stock, insider transaction, Form 4